World-renowned experts in the management of hematologic malignancies will present the latest treatment advances, updates to the standard of care as recommended in the NCCN Guidelines, and unique and challenging patient cases.

The NCCN Nursing Forum: Advancing Oncology Nursing in Hematologic Malignancies at the NCCN 2019 Annual Congress: Hematologic Malignancies will provide hematology/oncology nurses with comprehensive and clinically relevant information to optimize patient education and care.

ANCO's 2019 Professional Education Meeting will focus on CMS regulatory, coding & billing updates; USP797/800 compliance; patient satisfaction & its impact on MACRA; and, Federal and California legislative updates.

The 8th International Congress on Cancer Metastasis brings together international experts in oncology, immunobiology, pharmacology, molecular biology, and molecular imaging to discuss preclinical, translational, and clinical advances in diagnosing, treating, and preventing cancer metastasis as we enter the era of precision medicine.

The 2nd Kaiser Permanente National Oncology Symposium will bring together oncologists, researchers, and program administrators from all disciplines and regions to learn, share, and network. National experts will address cancer immunotherapy, molecular genomics, patient care management, value in oncology, and much more.

ANCO and UC San Francisco are collaborating on a Precision Oncology Symposium on November 9 at the Marines Memorial Club & Hotel in San Francisco. The Symposium is chaired by W. Michael Korn, MD, UC San Francisco. Precision oncology promises to improve the outcomes of patients through broad molecular diagnostic profiling and individualized treatment recommendations. Recent FDA...

The North American Neuroendocrine Tumor Society (NETS) and the University of California, San Francisco invite you to attend a valuable medical education conference on the multidisciplinary management of neuroendocrine disease.

The faculty will present the latest research on treatment modalities for hematologic malignancies--leukemias, lymphomas, and myeloma--along with case studies fo these diagnoses. The faculty will be Charalambos (Babis) Andreadis, MD, UC San Francisco; Brian A. Jonas, MD, PhD, UC Davis; Michaela Liedtke, MD, Stanford University; and, Swetha Kambhampati, MD, UC San Francisco.

This conference offers a comprehensive update on lung cancer screening and smoking cessation, emerging biomarkers and targeted therapy, interdisciplinary efforts with medical, radiation & surgical oncology, NSCLC, SCLC, and the evolving role of supportive therapy.